Thurston Springer Miller Herd & Titak’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187K Buy
374
+235
+169% +$113K 0.07% 262
2026
Q1
$68.3K Buy
139
+71
+104% +$38.5K 0.03% 477
2025
Q4
$39.4K Buy
68
+45
+196% +$25.4K 0.01% 551
2025
Q3
$11.2K Sell
23
-121
-84% -$56.3K 0.02% 342
2025
Q2
$58.5K Hold
144
0.01% 635
2025
Q1
$71.7K Sell
144
-22
-13% -$11.9K 0.01% 532
2024
Q4
$86.4K Buy
166
+71
+75% +$39K 0.02% 417
2024
Q3
$58.8K Sell
95
-116
-55% -$68.7K 0.02% 526
2024
Q2
$117K Buy
+211
New +$121K 0.04% 387

Other funds holding TMO

Thurston Springer Miller Herd & Titak's TMO Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Thermo Fisher Scientific (TMO) stake by 169% in Q2 2026, buying an estimated $113K and bringing the position to 374 shares worth $187K. The position accounts for 0.07% of the portfolio, ranked #262.

Thurston Springer Miller Herd & Titak first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 374 shares of Thermo Fisher Scientific worth $187K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 235 Thermo Fisher Scientific shares in Q2 2026, an estimated $113K.
  • Thermo Fisher Scientific made up 0.07% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #262 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.